Latest News

GLC Medical (GLCM) Inc. is pleased to announce the signing of a Memorandum
of Understanding (MoU) with a very significant UAE company with the intent to advance the GLCM Biosensor Platform to commercialization.

Completion of the development of its GLCM Biosensor Test Platform

May be used to detect other diseases

Donna Mandau, President and CEO of Graphene Leaders Canada Inc., was invited to speak with Mark Connolly and Tara McCarthy on CBC Radio.

An Edmonton company is gearing up to offer what it believes is the world’s fastest COVID-19 detection test, which would also eliminate the need for a nasal swab.

Donna Mandau, President and CEO of Graphene Leaders Canada Inc. and J'lyn Nye discuss the development of GLCM’s SARS-CoV-2 Insta-Test. 

GLC Medical (GLCM) Inc. is pleased to announce completion of development of the GLCM SARS-CoV-2 Insta-Test, delivering results in under 15 seconds, offering the world the fastest, easiest to use and most cost-effective solution to screen for COVID-19.

Edmonton International Airport has been chosen as the exclusive location to trial a new COVID-19 test that can produce results in seconds.

Graphene Leaders Canada (GLC) Inc. together with subsidiary GLC Medical (GLCM) Inc. announce their development of a graphene-enhanced sensor for use in their COVID-19 Rapid Test delivering accurate and reliable results in seconds.